Article Listing - Bristol-Myers fourth quarter below analysts estimates

US RESPIRATORY DRUG MARKET

11 May 1992

The US market for respiratory drug products will more than double in terms of sales value within the next five...

ERIC PENSER REGAINS SHARE IN CORTECS

11 May 1992

Eric Penser, a Swedish financier, has returned as the largest shareholder of Cortecs International, after regaining full ownership of the...

LOW-STRENGTH HALCION LAUNCHED IN FRANCE

11 May 1992

Upjohn has launched a 125ug tablet formulation of its hypnotic product Halcion (triazolam) onto the French market. At the end...

NEBULIZED ANP IN ASTHMA

11 May 1992

Researchers in Scotland have published a study in the British Medical Journal ((May 2), which demonstrates that nebulised atrial natriuretic...

CHAIN SALES OF RX DRUGS GROWING

11 May 1992

Sales of prescription drugs by US chain drugs stores reached $17 billion in 1991, and during the year the stores...

CHIRON'S IL-2 APPROVED IN USA

11 May 1992

Marking the end of an eight-year struggle, US biotechnology company Chiron has received approval from the Food and Drug Administration...

ITALIAN DRUG SPENDING FORECASTS

11 May 1992

Italy's 1992 drug spending deficit will be between 2,670 billion lire ($2.1 billion) and 3,832 billion lire ($3 billion), says...

EUROPEAN ATHRITIS THERAPY MARKET

11 May 1992

The western European market for arthritis treatment products is estimated to have been worth $1.58 billion in 1991, says a...

SWEDEN'S PHARMA MARKET IN 1991

11 May 1992

Pharmaceutical sales in Sweden increased by 11.9% last year to reach 7.9 billion Swedish kroner ($1.3 billion) from 7.1 billion...

CONNAUGHT'S VACCINE RESEARCH PROGRAM

11 May 1992

Canadian vaccines specialist Connaught Laboratories is approaching the halfway point of its five-year, C$29 million ($24.5 million) vaccine research program...

Showing 94031-94040 of 95376 articles